Page last updated: 2024-11-01

ofloxacin and Acquired Immune Deficiency Syndrome

ofloxacin has been researched along with Acquired Immune Deficiency Syndrome in 6 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Research Excerpts

ExcerptRelevanceReference
"The classic histologic presentation of bacillary angiomatosis involves three components: a lobular proliferation of capillaries with enlarged endothelial cells, neutrophilic debris, and clumps of finely granular material identified as bacteria with staining techniques."1.33Bacillary angiomatosis associated with pseudoepitheliomatous hyperplasia. ( Amsbaugh, S; Huiras, E; Wang, NS; Warren, S; Wever, A, 2006)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kelley, CF1
Armstrong, WS1
Eaton, ME1
Amsbaugh, S1
Huiras, E1
Wang, NS1
Wever, A1
Warren, S1
Maranetra, KN1
el-Chaar, GM1
Schwenk, MH1
Bardini, J1
Caliendo, G1
Frank, C1
Profeta, LM1
Talbot, KA1
Cohen, H1
Nozaki-Renard, J1
Iino, T1
Sato, Y1
Marumoto, Y1
Ohta, G1
Furusawa, M1

Reviews

2 reviews available for ofloxacin and Acquired Immune Deficiency Syndrome

ArticleYear
Treatment of multidrug-resistant tuberculosis in Thailand.
    Chemotherapy, 1996, Volume: 42 Suppl 3

    Topics: Acquired Immunodeficiency Syndrome; Ambulatory Care Facilities; Clinical Trials as Topic; Drug Resis

1996
New drugs on the horizon.
    Clinics in podiatric medicine and surgery, 1992, Volume: 9, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Aminosalicylic Acids; Antibodies, Monoclonal; Antibodies, Monocl

1992

Other Studies

4 other studies available for ofloxacin and Acquired Immune Deficiency Syndrome

ArticleYear
Disseminated Mycobacterium haemophilum infection.
    The Lancet. Infectious diseases, 2011, Volume: 11, Issue:7

    Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Anti-HIV Agents; Cellulitis; Clarithromyc

2011
Bacillary angiomatosis associated with pseudoepitheliomatous hyperplasia.
    The American Journal of dermatopathology, 2006, Volume: 28, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Angiomatosis, Bacillary;

2006
Fluoroquinolones protect the human lymphocyte CEM cell line from HIV-1-mediated cytotoxicity.
    Cell structure and function, 1990, Volume: 15, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Cell Line; Cell Survival; Ciprofloxacin; Enoxacin; HIV-1; Humans

1990
[Rifabutine in the treatment of mycobacterial infections resistant to rifampicin. Preliminary results. Group for the Study and Treatment of Resistant Mycobacterial Infections (GETIM)].
    Revue des maladies respiratoires, 1989, Volume: 6, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Drug Resistance, Microbial; Drug Therapy, Combinati

1989